S

SIXTH ELEMENT CAPITAL LLP

4 employees

Sixth Element Capital is a firm specializing in early stage investment.

Investor insights

Sectors invested in

Therapeutics7
Biotechnology7
Oncology3
Translational Medicine3
Drug Discovery3
Cancer3
Translation Service3
Simulation3
Small Molecule Therapeutics3
Genetics3
Immuno-oncology3
Pharmaceutical1
Health Care1

Funding rounds participated in

$10M sweet spot round size

Most of their 7 investments are in rounds between $5.1M and $11M

Investor type

Venture Capital

Basic info

Sectors

Health Diagnostics
Health Care

Date founded

2010

Investments made

N

NeoPhore Ltd raised $7.4M on January 19, 2023

Investors: Astellas Venture Capital L.L.C., 3B Future Health Fund, Claris Ventures SGR SpA and SIXTH ELEMENT CAPITAL LLP

N

NeoPhore Ltd raised $21M on March 9, 2021

Investors: Astellas Venture Capital L.L.C., 3B Future Health Fund, 2invest financial, Claris Ventures SGR SpA and SIXTH ELEMENT CAPITAL LLP

A

Azeria Therapeutics Limited raised $41M on November 21, 2019

Investors: Syncona Limited and SIXTH ELEMENT CAPITAL LLP

A

Azeria Therapeutics Limited raised $5.1M on September 4, 2018

Investors: SIXTH ELEMENT CAPITAL LLP

A

AdoRx raised $10M on June 21, 2018

Investors: Epidarex Capital and SIXTH ELEMENT CAPITAL LLP

N

NeoPhore Ltd raised $4M on November 16, 2017

Investors: SIXTH ELEMENT CAPITAL LLP

M

Macrophage Pharma raised $11M on January 9, 2017

Investors: M Ventures, Novo Holdings and SIXTH ELEMENT CAPITAL LLP

FAQ